
|Articles|September 1, 2002
Intermittent androgen withdrawal as effective as continuous
Orlando, FL-Intermittent androgen deprivation appears to be as effectiveas continuous androgen deprivation in the treatment of advanced prostatecancer, say researchers from the University of Liege, Belgium.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Laura Bukavina, MD, and Gabriela Díaz, MD, on the rise of young-onset bladder cancer
3
Individualizing androgen pathway therapy in mCSPC
4
BOND-003 Cohort C: Efficacy Results
5








